Special Issue on Design of Imaging Probe for in-Vivo/ in-Vitro Imaging for Early Detection for Tumor/ Infection

Submission Deadline: Feb. 20, 2020

This special issue currently is open for paper submission and guest editor application.

Please download to know all details of the Special Issue

Special Issue Flyer (PDF)

  • Special Issue Editor
    • Dr. Ravi Ranjan Kumar
      Centre for Nuclear Medicine, Panjab University Chandigarh, Chandigarh, India
    Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to fulfill the Guest Editor application.
    • Dr. Rakhee Vatsa
      Post Graduate Institute of Medical Sciences and Research, Chandigarh, India
    • Dr. Nividita Rana
      Post Graduate Institute of Medical Sciences and Research, Chandigarh, India
    • Dr. Munish Kumar
      Department of Chemistry, DAV college, Chandigarh, India
    • Dr. Mahmoud Sanad
      Egypt Atomic Energy Authority, Cairo, Egypt
    • Dr. Gawsia Jaan
      Department of Radiotherapy, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India
    • Anshoo Malhotra
      Department of Biophysics, Post Graduate Institute of Medical Education and Research, Chandigarh, India
  • Introduction

    In-vivio imaging is an emerging area in biomedical sciences, which basically covered all aspect of basic science. The primary point for this issue is to acknowledge the fundamental role of biophysical science in cancer imaging. Role of gamma emitting radioisotopes in in-vivo imaging is considering one of the best techniques over the other imaging modalities such as MRI and fluorescent imaging. This issue would be covering the designing the radionuclide imaging probe, radioisotope availability for imaging cancer biology, biophysico-chemico analysis. Currently the role of in-vivo imaging sparks the cancer diagnosis and staging in medical sciences. 18FDG is currently being used foe diagnosis and staging the cancer via positron emission tomography. Hence designing the radionuclide probe (Radiopharmaceutical) has tremendous opportunities for scientists. This current issue may provide researcher to learn various advancements in the field of in-vivo imaging which is vital part of radiation biophysics. Novel research articles are solicited in any aspect of innovative biomedical research in radiation biophysics.
    Aims and Scope:
    1. Radio nuclide Imaging for cancer/infection
    2. Nanoparticle Synthesis and In-vitro imaging
    3. Molecular Imaging
    4. Biophysical chemistry
    5. Cytotoxicity
    6. Radiopharmaceutical science

  • Guidelines for Submission

    Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.

    Papers should be formatted according to the guidelines for authors (see: http://www.ejbiophysics.org/submission). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.

  • Published Papers

    The special issue currently is open for paper submission. Potential authors are humbly requested to submit an electronic copy of their complete manuscript by clicking here.

Browse journals by subject